MedPath

Dietary Reversal of the Reprometabolic Syndrome

Not Applicable
Active, not recruiting
Conditions
Obesity & Overweight
Infertility, Female
Registration Number
NCT07227766
Lead Sponsor
University of Colorado, Denver
Brief Summary

This study proposes to test the specific question that a eucaloric, low-fat diet given to women with obesity will result in an increase in reproductive hormones.

Detailed Description

This an open-label, multi site study in pre-menopausal women aged 18-40 years old with a history of regular menstrual cycles (25-35 days long) of high BMI. The objective of the study will be to determine the effects of a one month long, eucaloric low-fat diet on reproductive hormone levels in women with a high BMI. The study will occur over 4 menstrual cycle (approximately 4 months). During the study the participants will have a pre-diet cycle where no food will be consumed, an on-diet cycle where the customized low-fat diet will be consumed, and two post diet cycles. First morning voided urine will be collected during all four cycles along with 3 blood draws during the study. Participants will be asked to use a reliable barrier method of birth control or abstain from intercourse during the study.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Normal TSH and prolactin
  • Regular menstrual cycles every 25-40 days
  • No history of chronic disease affecting hormone production, metabolism or clearance
  • No use of reproductive hormones, or medications/supplements known to impact them, within 3 months of enrollment
  • Use of a reliable method of contraception (female or male partner sterilization, IUD, abstinence, diaphragm or cervical cap)
  • Normal ovarian reserve (AMH of 0.5ng/ml or greater)
  • Normal testosterone levels at screening or absence of clinical evidence of hyperandrogenemia (acne, facial hirsutism [defined as Ferriman-Gallwey score>8] or alopecia)
Exclusion Criteria
  • Baseline dietary assessment indicative of 28% or less daily calories from fat
  • Inability to comply with the protocol (many meals per week eaten outside of the home, frequent travel)
  • Pregnancy or planned pregnancy within next 6 months at time of screening
  • HbA1C >6.5%

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Urinary Pregnadiol Glucouronide concentration in ug/mg creatinineFrom enrollment for 4 months post enrollment
Secondary Outcome Measures
NameTimeMethod
Amount of Urinary estrogenFrom enrollment to 4 months

Urinary estrogen concentration in microgram/mg of Creatinine

Trial Locations

Locations (1)

University of Colorado School of Medicine

🇺🇸

Aurora, Colorado, United States

University of Colorado School of Medicine
🇺🇸Aurora, Colorado, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.